AAAAAA

   
Results: 1-7 |
Results: 7

Authors: WEDEMEYER H PETZOLD DR BOEKER KHW PETHIG K TILLMANN HL GAMBURG E BAST M HAVERICH A MANNS MP
Citation: H. Wedemeyer et al., AMINO-ACID CHANGES OF HBV-POLYMERASE PRIOR TO AND DURING FAMCICLOVIR TREATMENT IN IMMUNOSUPPRESSED PATIENTS WITH CHRONIC HEPATITIS-B, Hepatology, 28(4), 1998, pp. 1310-1310

Authors: WALMSLEY S LEVINTON C BRUNTON J MURADALI D RAPPAPORT D BAST M SPENCE D SALIT I
Citation: S. Walmsley et al., A MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF ADJUNCTIVE CORTICOSTEROIDS IN THE TREATMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA COMPLICATING THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME, Journal of acquired immune deficiency syndromes and human retrovirology, 8(4), 1995, pp. 348-357

Authors: GRIERSON HL WOOLDRIDGE TN HESS M RATASHAK A WOOLDRIDGE L FORDYCEBOYER R BAST M ARMITAGE JO WEISENBURGER DD SANGER WG
Citation: Hl. Grierson et al., PROLIFERATIVE FRACTION AND DNA CONTENT ARE LOWER IN B-CELL NON-HODGKINS-LYMPHOMAS WITH THE T(14-18), Leukemia & lymphoma, 19(3-4), 1995, pp. 253-257

Authors: GRIERSON HL WOOLDRIDGE TN HESS M WOOLDRIDGE L RATASHAK A BAST M ARMITAGE JO WEISENBURGER DD SANGER WG
Citation: Hl. Grierson et al., COMPARISON OF DNA CONTENT IN NON-HODGKINS-LYMPHOMA AS MEASURED BY FLOW-CYTOMETRY AND CYTOGENETICS, Cancer genetics and cytogenetics, 80(2), 1995, pp. 124-128

Authors: VOSE JM ANDERSON JR BIERMAN PJ BAST M WEISENBURGER D CHAN WC BISHOP MR ARMITAGE JO
Citation: Jm. Vose et al., COMPARISON OF FRONT-LINE CHEMOTHERAPY FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA USING THE CAP-BOP REGIMENS, Seminars in hematology, 31(2), 1994, pp. 4-8

Authors: TEZCAN H VOSE J BAST M WEISENBURGER D BIERMAN P KESSINGER A ARMITAGE JO
Citation: H. Tezcan et al., LIMITED STAGE FOLLICULAR NON-HODGKINS-LYMPHOMA - THE NEBRASKA LYMPHOMA STUDY-GROUP (NLSG) EXPERIENCE, Blood, 84(10), 1994, pp. 10000383-10000383

Authors: VOSE JM WEISENBURGER DD ANDERSON JR BIERMAN PJ BAST M CHAN WJ BISHOP MR ARMITAGE JO
Citation: Jm. Vose et al., MANTLE CELL LYMPHOMA (MCL) HAS A POORER PROGNOSIS THAN FOLLICULAR NON-HODGKINS-LYMPHOMA (F-NHL) - HOWEVER, HIGH-DOSE THERAPY (HDC) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) MAY OVERCOME TREATMENT RESISTANCE IN MCL, Blood, 82(10), 1993, pp. 10000135-10000135
Risultati: 1-7 |